ArticleFrontiers in genetics2022
Missing Value Imputation With Low-Rank Matrix Completion in Single-Cell RNA-Seq Data by Considering Cell Heterogeneity.
Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Exposure-inducible genes may contribute to missingness in RNAseq-based gene expression analyses.Scientific reports · 2025Article
- Addressing Missing Data Challenges in Geriatric Health Monitoring: A Study of Statistical and Machine Learning Imputation Methods.Sensors (Basel, Switzerland) · 2025Article
- Imputation method for single-cell RNA-seq data using neural topic model.GigaScience · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Single-cell RNA-sequencing (scRNA-seq) technologies enable the measurements of gene expressions in individual cells, which is helpful for exploring cancer heterogeneity and precision medicine. However, various technical noises lead to false zero values (missing gene expression values) in scRNA-seq data, termed as dropout events. These zero values complicate the analysis of cell patterns, which affects the high-precision analysis of intra-tumor heterogeneity. Recovering missing gene expression values is still a major obstacle in the scRNA-seq data analysis. In this study, taking the cell heterogeneity into consideration, we develop a novel method, called single cell Gauss-Newton Gene expression Imputation (scGNGI), to impute the scRNA-seq expression matrices by using a low-rank matrix completion. The obtained experimental results on the simulated datasets and real scRNA-seq datasets show that scGNGI can more effectively impute the missing values for scRNA-seq gene expression and improve the down-stream analysis compared to other state-of-the-art methods. Moreover, we show that the proposed method can better preserve gene expression variability among cells. Overall, this study helps explore the complex biological system and precision medicine in scRNA-seq data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.